Intestinal levels of anandamide and oleoylethanolamide in food-deprived rats are regulated through their precursors

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1761, Issue 2, 2006, Pages 143-150

  Petersen, Gitte ^a   Sørensen, Camilla ^a   Schmid, Patricia C ^b   Artmann, Andreas ^a   Tang Christensen, Mads ^c   Hansen, Steen H ^a   Larsen, Philip Just ^c   Schmid, Harald H O ^b   Hansen, Harald S ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Rheoscience ^*  (Denmark)

Author keywords

2 arachidonoyl glycerol; Anandamide; Linoleoylethanolamide; N Acyltransferase; Oleoylethanolamide

Indexed keywords

2 ARACHIDINOYLGLYCEROL; ACYLTRANSFERASE; AMIDE; ANANDAMIDE; ETHANOLAMINE DERIVATIVE; FATTY ACID; GLYCEROL; LINOLEOYLETHANOLAMIDE; LIPID; N ACYLPHOSPHATIDYLETHANOLAMINE; N OLEOYLETHANOLAMINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPASE D; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATALYSIS; CHEMICAL ANALYSIS; FEEDING; FOOD DEPRIVATION; FOOD INTAKE; HYDROLYSIS; MALE; MOLECULE; NONHUMAN; PRECURSOR; PRIORITY JOURNAL; RAT; STARVATION; TISSUE LEVEL;

ANIMALS; ARACHIDONIC ACIDS; EATING; FOOD DEPRIVATION; INTESTINES; MALE; OLEIC ACIDS; PHOSPHOLIPIDS; POLYUNSATURATED ALKAMIDES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33646486532     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00239-004-0305-3     Document Type: Article

References (61)

1. Schmid H.H.O., Schmid P.C., and Natarajan V. N-Acylated glycerophospholipids and their derivatives. Prog. Lipid Res. 29 (1990) 1-43
2. Hansen H.S., Moesgaard B., Petersen G., and Hansen H.H. Putative neuroprotective actions of N-acyl-ethanolamines. Pharmacol. Ther. 95 (2002) 119-126
3. Schmid H.H.O., Schmid P.C., and Berdyshev E.V. Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges. Chem. Phys. Lipids 121 (2002) 111-134
4. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., and Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258 (1992) 1946-1949
5. Cravatt B.F., and Lichtman A.H. The enzymatic inactivation of the fatty acid amide class of signaling lipids. Chem. Phys. Lipids 121 (2002) 135-148
6. Alger B.E. Endocannabinoids: getting the message across. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 8512-8513
7. Hansen H.S., Moesgaard B., Hansen H.H., and Petersen G. N-acylethanolamines and precursor phospholipids-Relation to cell injury. Chem. Phys. Lipids 108 (2000) 135-150
8. Schmid H.H.O. Pathways and mechanisms of N-acylethanolamine biosynthesis: can anandamide be generated selectively?. Chem. Phys. Lipids 108 (2000) 71-87
9. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., Yamashita A., and Waku K. 2-Arachidonoylgylcerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215 (1995) 89-97
10. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., Compton D.R., Pertwee R.G., Griffin G., Bayewitch M., Barg J., and Vogel Z. Identification of en endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50 (1995) 83-90
11. Sugiura T., Kodaka T., Nakane S., Miyashita T., Kondo S., Suhara Y., Takayama H., Waku K., Seki C., Baba N., and Ishima Y. Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor-structure-activity relationship of 2-arachidonoylglycerol ether-linked analogues, and related compounds. J. Biol. Chem. 274 (1999) 2794-2801
12. Sugiura T., Kondo S., Kishimoto S., Miyashita T., Nakane S., Kodaka T., Suhara Y., Takayama H., and Waku K. Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor-Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J. Biol. Chem. 275 (2000) 605-612
13. Izzo A.A., Fezza F., Capasso R., Bisogno T., Pinto L., Iuvone T., Esposito G., Mascolo N., Di Marzo V., and Capasso F. Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation. Br. J. Pharmacol. 134 (2001) 563-570
14. Mechoulam R., Fride E., and Di Marzo V. Endocannabinoids. Eur. J. Pharmacol. 359 (1998) 1-18
15. Patricelli M.P., and Cravatt B.F. Proteins regulating the biosynthesis and inactivation of neuromodulatory fatty acid amides. Vitam. Horm. 62 (2001) 95-131
16. Rodriguez de Fonseca F., Navarro M., Gomez R., Escuredo L., Nava F., Fu J., Murillo-Rodriguez E., Giuffrida A., LoVerme J., Gaetani S., Kathuria S., Gall C., and Piomelli D. An anorexic lipid mediator regulated by feeding. Nature 414 (2001) 209-212
17. Fu J., Gaetani S., Oveisi F., Lo Verme J., Serrano A., Rodriguez de Fonseca F., Rosengarth A., Luecke H., Di Giacomo B., Tarzia G., and Piomelli D. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α. Nature 425 (2003) 90-93
18. Gaetani S., Oveisi F., and Piomelli D. Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide. Neuropsychopharmacology 28 (2003) 1311-1316
19. Nielsen M.J., Petersen G., Astrup A., and Hansen H.S. Food intake is inhibited by oral oleoylethanolamide. J. Lipid Res. 45 (2004) 1027-1029
20. Oveisi F., Gaetani S., Eng K.T., and Piomelli D. Oleoylethanolamide inhibits food intake in free-feeding rats after oral administration. Pharmacol. Res. 49 (2004) 461-466
21. Williams C.M., and Kirkham T.C. Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology (Berl.) 143 (1999) 315-317
22. Williams C.M., and Kirkham T.C. Observational analysis of feeding induced by Delta9-THC and anandamide. Physiol. Behav. 76 (2002) 241-250
23. Izzo A.A., Mascolo N., and Capasso F. The gastrointestinal pharmacology of cannabinoids. Curr. Opin. Pharmacol. 1 (2001) 597-603
24. Hornby P.J., and Prouty S.M. Involvement of cannabinoid receptors in gut motility and visceral perception. Br. J. Pharmacol. 141 (2004) 1335-1345
25. Di Marzo V., Goparaju S.K., Wang L., Liu J., Bátkai S., Járai Z., Fezza F., Miura G.I., Palmiter R.D., Sugiura T., and Kunos G. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410 (2001) 822-825
26. Ramos E.J., Meguid M.M., Campos A.C., and Coelho J.C. Neuropeptide Y, α-melanocyte-stimulating hormone, and monoamines in food intake regulation. Nutrition 21 (2005) 269-279
27. Gomez R., Navarro M., Ferrer B., Trigo J.M., Bilbao A., Del A., Cippitelli I.A., Nava F., Piomelli D., and Rodriguez de Fonseca F. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J. Neurosci. 22 (2002) 9612-9617
28. Giuffrida A., Rodriguez D.F., and Piomelli D. Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry. Anal. Biochem. 280 (2000) 87-93
29. Tang-Christensen M., Vrang N., Ortmann S., Bidlingmaier M., Horvath T.L., and Tschop M. Central administration of ghrelin and agouti-related protein (83-132) increases food intake and decreases spontaneous locomotor activity in rats. Endocrinology 145 (2004) 4645-4652
30. Schmid P.C., Schwartz K.D., Smith C.N., Krebsbach R.J., Berdyshev E.V., and Schmid H.H.O. A sensitive endocannabinoid assay. The simultaneous analysis of N-acylethanolamines and 2-monoacylglycerols. Chem. Phys. Lipids 104 (2000) 185-191
31. Hansen H.H., Schmid P.C., Bittigau P., Lastres-Becker I., Berrendero F., Manzanares J., Ikonomidou C., Schmid H.H.O., Fernandez-Ruiz J.J., and Hansen H.S. Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration. J. Neurochem. 78 (2001) 1415-1427
32. Folch J., Lees M., and Stanley G.H.S. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226 (1957) 497-509
33. Bartlett G.R. Phosphorous assay in column chromatography. J. Biol. Chem. 234 (1959) 466-468
34. Moesgaard B., Petersen G., Mortensen S.A., and Hansen H.S. Substantial species differences in relation to formation and degradation of N-acyl-ethanolamine phospholipids in heart tissue: an enzyme activity study. Comp. Biochem. Physiol., Part B: Biochem. Mol. Biol. 131 (2002) 475-482
35. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
36. Kirazov L.P., Venkov L.G., and Kirazov E.P. Comparison of the Lowry and the Bradford protein assays as applied for protein estimation of membrane-containing fractions. Anal. Biochem. 208 (1993) 44-48
37. 31P NMR and enzyme activity study. J. Lipid Res. 41 (2000) 985-990
38. Petersen G., Chapman K.D., and Hansen H.S. A rapid phospholipase D assay using zirconium precipitation of anionic substrate phospholipids: application to N-acylethanolamine formation in vitro. J. Lipid Res. 41 (2000) 1532-1538
39. Moesgaard B., Hansen H.H., Hansen S.L., Hansen S.H., Petersen G., and Hansen H.S. Brain levels of N-acylethanolamine phospholipids in mice during pentylenetetrazol-induced seizure. Lipids 38 (2003) 387-390
40. 14C] as a substrate for anandamide amidase. Life Sci. 56 (1995) 1999-2005
41. Katayama K., Ueda N., Kurahashi Y., Suzuki H., Yamamoto S., and Kato I. Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine. Biochim. Biophys. Acta, Lipids Lipid Metab. 1347 (1997) 212-218
42. Garg M.L., Keelan M., Thomson A.B., and Clandinin M.T. Desaturation of linoleic acid in the small bowel is increased by short-term fasting and by dietary content of linoleic acid. Biochim. Biophys. Acta 1126 (1992) 17-25
43. Waheed A.A., Yasuzumi F., and Gupta P.D. Lipid and fatty acid composition of brush border membrane of rat intestine during starvation. Lipids 33 (1998) 1093-1097
44. Patel S., Carrier E.J., Ho W.S., Rademacher D.J., Cunningham S., Reddy D.S., Falck J.R., Cravatt B.F., and Hillard C.J. The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity. J. Lipid Res. 46 (2005) 342-349
45. Cadas H., Di Tomaso E., and Piomelli D. Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. J. Neurosci. 17 (1997) 1226-1242
46. Kirkham T.C., Williams C.M., Fezza F., and Di Marzo V. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br. J. Pharmacol. 136 (2002) 550-557
47. Berry E.M., and Mechoulam R. Tetrahydrocannabinol and endocannabinoids in feeding and appetite. Pharmacol. Ther. 95 (2002) 185-190
48. McVeigh D.C., Schmid P.C., Schmid H.H.O., and Vigna S.R. Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1). J. Pharmacol. Exp. Ther. 304 (2003) 713-722
49. Pertwee R.G. Cannabinoids and the gastrointestinal tract. Gut 48 (2001) 859-867
50. Pinto L., Capasso R., Di Carlo G., and Izzo A.A. Endocannabinoids and the gut. Prostaglandins Leukot. Essent. Fat. Acids 66 (2002) 333-341
51. Capasso R., Izzo A.A., Fezza F., Pinto A., Capasso F., Mascolo N., and Di Marzo V. Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice. Br. J. Pharmacol. 134 (2001) 945-950
52. Smart D., Jonsson K.O., Vandevoorde S., Lambert D.M., and Fowler C.J. 'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism. Br. J. Pharmacol. 136 (2002) 452-458
53. Wang X., Miyares R.L., and Ahern G.P. Oleoylethanolamide excites vagal sensory neurones, induces visceral pain and reduces short-term food intake in mice via capsaicin receptor TRPV1. J. Physiol. 564 (2005) 541-547
54. Lo Verme J., Gaetani S., Fu J., Oveisi F., Burton K., and Piomelli D. Regulation of food intake by oleoylethanolamide. Cell. Mol. Life Sci. 62 (2005) 708-716
55. Thorens B., and Larsen P.J. Gut-derived signaling molecules and vagal afferents in the control of glucose and energy homeostasis. Curr. Opin. Clin. Nutr. Metab. Care 7 (2004) 471-478
56. Larsen P.J., Jensen P.B., Sorensen R.V., Larsen L.K., Vrang N., Wulff E.M., and Wassermann K. Differential influences of peroxisome proliferator-activated receptors gamma and -alpha on food intake and energy homeostasis. Diabetes 52 (2003) 2249-2259
57. Guzmán M., Lo Verme J., Fu J., Oveisi F., Blázquez C., and Piomelli D. Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor α (PPAR-α). J. Biol. Chem. 279 (2004) 27849-27854
58. Hansen H.H., Ikonomidou C., Bittigau P., Hansen S.H., and Hansen H.S. Accumulation of the anandamide precursor and other N-acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal death. J. Neurochem. 76 (2001) 39-46
59. Berger C., Schmid P.C., Schabitz W.R., Wolf M., Schwab S., and Schmid H.H.O. Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia?. J. Neurochem. 88 (2004) 1159-1167
60. Keelan M., Wierzbicki A., Clandinin M.T., Walker K., and Thomson A.B. Alterations in dietary fatty acid composition alter rat brush border membrane phospholipid fatty acid composition. Diabetes Res. 14 (1990) 165-170
61. Terrazzino S., Berto F., Carbonare M.D., Fabris M., Guiotto A., Bernardini D., and Leon A. Stearoylethanolamide exerts anorexic effects in mice via downregulation of liver stearoyl-coenzyme A desaturase-1 mRNA expression. FASEB J. 18 (2004) 1580-1582